Bavarian Nordic in talks to expand monkeypox vaccine output

Bavarian Nordic in talks to expand monkeypox vaccine output Bavarian Nordic , the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said on Monday. Natalie Grover Reuters

...

The Copenhagen-based vaccine maker has a vaccine that goes by the brand name Jynneos, Imvamune or Imvanex - depending on geography. It has U.S. and European approval for its use in the prevention of monkeypox, as well as the closely-related smallpox...